Table 1.
Clinical characteristics of the patients in the 2 groups.
| Characteristic | CR group (n = 5) | Non-CR group (n = 4) |
|---|---|---|
| Age, years | ||
| Median (range) | 42 (27-58) | 55 (22-71) |
| Sex, male | 2 | 2 |
| Ann Arbor stage III/IV | 3 | 3 |
| ECOG performance status>1 | 2 | 1 |
| IPI score>2 | 1 | 1 |
| Histologic subtypes | ||
| PTCL, NOS | 1 | 1 |
| AITL | 2 | 2 |
| ALK- ALCL | 2 | 1 |
ECOG, Eastern Cooperative Oncology Group; IPI, International Prognostic Index; PTCL, NOS, peripheral T-cell lymphoma; not otherwise specified; AITL, angioimmunoblastic T-cell lymphoma; ALK- ALCL, anaplastic large cell lymphoma, ALK negative.